Eisai
ESALYDrugs in Pipeline
156
Phase 3 Programs
80
Upcoming Catalysts
12
Next Catalyst
Nov 2026
Market Overview
Stock performance and key metrics
12 upcoming, 1 past
Zolpidem tartrate
Insomnia
menatetranone
Postmenopausal Osteoporosis
Eszopiclone 1 mg- Elderly
Insomnia
Rabeprazole ER
Gastroesophageal Reflux Disease (GERD)
Rabeprazole sodium
Gastroesophageal Reflux Disease (GERD)
Sibutramine Hydrochloride Monohydrate
Obesity
Dotinurad
Gout
lemborexant
Insomnia Disorder
E3810
Non-erosive Gastroesophageal Reflux Disease
Lamotrigine
Epilepsy
Perampanel
Epilepsy
T-614
Rheumatoid Arthritis
Lorcaserin 10 mg once daily (QD)
Obesity
Lorcaserin 10 mg twice a day (BID)
Obesity
E2007 (perampanel)
Refractory Partial Seizures
fospropofol disodium
Colonoscopy
methylcobalamin
Amyotrophic Lateral Sclerosis
Rufinamide
Lennox-Gastaut Syndrome
Carbamazepine
Epilepsy
bexarotene
Non-small Cell Lung Cancer
Lecanemab
Preclinical Alzheimer's Disease
E2007 (2 mg)
Diabetic Neuropathy
Eszopiclone 1 mg
Primary Insomnia
E7389
Breast Cancer
Midazolam HCl
Colonoscopy
LEM 5 mg
Insomnia
avatrombopag (higher baseline platelet count)
Thrombocytopenia Associated With Liver Disease
Cytarabine or Supportive Care
Acute Myeloid Leukemia
E2020
Alzheimer's Type Dementia
Irofulven
Prostate Cancer
Eribulin
Non-Small Cell Lung Cancer (NSCLC)
Zonisamide
Epilepsy; Paediatric Partial Onset Seizures
Aricept
Cognitive Impairment
Eribulin Mesylate
Breast Cancer
Rufinamide (E2080)
Lennox-Gastaut Syndrome
avatrombopag (lower baseline platelet count)
Thrombocytopenia Associated With Liver Disease
Lorcaserin 10 mg BID
Obesity
Ranirestat
Mild to Moderate Diabetic Sensorimotor Polyneuropathy
eritoran tetrasodium
Severe Sepsis
Eribulin mesylate 1.4 mg/m^2 intravenous
Soft Tissue Sarcoma
Belzutifan
Carcinoma, Renal Cell
E2814
Alzheimer Disease
Avatrombopag
Chronic Thrombocytopenia
AQUAVAN® (fospropofol disodium) Injection
Bronchoscopy
Gantenerumab
Alzheimers Disease
E7777 9 mcg/kg
Persistent or Recurrent Cutaneous T-Cell Lymphoma
phylloquinone (K1)
Osteoporosis
Aricept (donepezil SR 23 mg)
Alzheimer's Disease
Teprenone
Gastric or Duodenal Ulcers Caused by Low-dose Aspirin
Doxorubicin
Breast Cancer
Donepezil 5 mg
Dementia With Lewy Bodies (DLB)
Oxaliplatin
Liver Cancer
everolimus
Renal Cell Carcinoma
Carboplatin
Endometrial Neoplasms
Sorafenib
Hepatocellular Carcinoma (HCC)
Docetaxel
Squamous Cell Carcinoma of Head and Neck
Decitabine
Acute Myeloid Leukemia
Donepezil hydrochloride
Attention Impairment
Cinitapride
Dyspepsia
Lenvatinib
Hepatocellular Carcinoma
E2007
Refractory Partial Seizures
Eperisone
Muscle Spasm; Back Pain
Eperisone hydrochloride and Diclofenac sodium
Acute Musculoskeletal Spasm Due to Low Back Pain
Zonegran
Binge Eating Disorder Associated With Obesity
Rabeprazole
Gastric Ulcers Duodenal Ulcers Caused by Low-dose Aspirin
Clevudine
Chronic Hepatitis B
Donepezil
Alzheimer's Disease
Ranitidine
Gastroesophageal Reflux Disease (GERD)
bexarotene with carboplatin and paclitaxel
Non-small Cell Lung Cancer
Amolimogene
Uterine Cervical Dysplasia
Donepezil HCl
Down Syndrome
E7337
Lesions of the Liver
Prior Donepezil 5mg
Parkinson's Disease
E0302 (mecobalamin)
Amyotrophic Lateral Sclerosis (ALS)
Leucovorin (or Levoleucovorin)
Advanced/Metastatic Gastroesophageal Adenocarcinoma
H. pylori treatment
Iron Deficiency Anemia
Physician's Choice
Breast Cancer
E7389 (Eribulin Mesylate)
HER2-Negative Breast Cancer
2 mg perampanel
Parkinson's Disease
Midazolam HCI
Conscious Sedation
Pegylated interferon (PEG-IFN)
Thrombocytopenia
E7080 capsule
Thyroid Cancer
BOTULINUM TOXIN TYPE B
Cervical Dystonia
E7777
Peripheral T-cell Lymphoma
Rabeprazole sodium, 5 mg Tablets
Healthy
E7090
Cholangiocarcinoma
E5555 50 mg
Coronary Artery Disease
Tazemetostat
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
E6742
Lupus Erythematosus, Systemic
E7050
Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
E2014 (Botulinum toxin type B)
Spasmodic Torticollis
Farletuzumab
Platinum-Sensitive Ovarian Cancer in First Relapse
Irofulven + capecitabine
Thyroid Cancer
BB-1701
Breast Cancer
E7449 alone
Malignant Solid Tumour
APD356
Obesity
ONTAK (denileukin diftitox)
Lymphoma, B-Cell
Iomeprole
Lesion
Eribulin mesilate
Refractory or Recurrent Solid Tumors
E7070
Kidney Neoplasms
Lenvatinib (DTC Cohort)
Thyroid Cancer
Palonosetron
Multiple Myeloma
E7080
Solid Tumors
ONTAK
Non-Hodgkin's Lymphoma
E6011
Rheumatoid Arthritis
GPI 1485
Parkinson's Disease
Denileukin diftitox
Stage IIIC Melanoma
Farletuzumab ecteribulin
Solid Tumor
E2006
Chronic Insomnia
E7820 plus cetuximab
Advanced Colorectal Cancer
Lecanemab 2.5 mg/kg
Alzheimer's Disease
GLIADEL
Metastatic Brain Cancer
palonesetron
Patients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LEC
H3B-6545
Breast Neoplasms
E7386
Melanoma
Avatrombopag tablets
Chronic Idiopathic Thrombocytopenic Purpura
AQUAVAN (fospropofol disodium; GPI 15715 )
Postoperative Sedation
Lemborexant 2.5 mg
Irregular Sleep-Wake Rhythm Disorder
E5564
Sepsis
Irsenontrine
Dementia With Lewy Bodies
E5555
Coronary Artery Disease
fospropofol
Ischemic Coronary Artery Disease
E6201 0.005%
Chronic Plaque Psoriasis
Rabeprazole 20 mg
Gastroesophageal Reflux Disease
E7389 28 Day Cycle
Non-Small-Cell Lung Carcinoma
Perampanel Oral Suspension
Pediatric Epileptic Syndrome
E7389-LF
Solid Neoplasms
Ixabepilone
Breast Cancer
MORAb-004 (monoclonal antibody)
Metastatic Melanoma
BSC
Non-Small Cell Lung Cancer
Open Label (Avatrombopag tablets)
Idiopathic Thrombocytopenic Purpura
E2027
Lewy Body Disease
0.03% E6201
Psoriasis Vulgaris
E2086
Narcolepsy
Rabeprazole 20 mg twice a day for 90-day period treatment
Postnasal Drainage
Clofarabine
Acute Myeloid Leukemia
Lenvatinib + Letrozole
Breast Cancer
E7820
Acute Myeloid Leukemia
decitabine (5-aza-2'deoxycytidine)
Chronic Myelogenous Leukemia
Valproic acid
Leukemia
Estrogen
Alzheimer Disease
Palonosetron (PALO)
Malignant Glioma
Idarubicin
Leukemia
Lenvatinib Pill
Hepatocellular Carcinoma
E2020-Donepezil hydrochloride
Down Syndrome
Gemtuzumab ozogamicin
Acute Myelogenous Leukemia
Adriamycin
Inflammatory Breast Cancer
Ondansetron
Acute Myelogenous Leukemia
3 mg Donepezil hydrochloride
Dementia With Lewy Bodies (DLB)
Eribulin mesylate (eribulin; E7389)
Non Small Cell Lung Cancer
Aricept (donepezil hydrochloride)
Migraine Headache
(+)-SJ000557733 (SJ733)
Malaria, Falciparum
eribulin mesylate + erlotinib
Non-small Cell Lung Cancer
Lemborexant 10 mg
Alzheimer Disease
CHOP (cyclophosphamide (C), adriamycin (H), vincristine (O), and prednisone (P)) chemotherapy
Peripheral T-Cell Lymphoma
Decitabine, Arsenic Trioxide and Ascorbic Acid
Myelodysplastic Syndrome
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Zolpidem tartrate | Phase 3 | Insomnia | - | - |
menatetranone | Phase 3 | Postmenopausal Osteoporosis | - | - |
Eszopiclone 1 mg- Elderly | Phase 3 | Insomnia | - | - |
Rabeprazole ER | Phase 3 | Gastroesophageal Reflux Disease (GERD) | - | - |
Rabeprazole sodium | Phase 3 | Gastroesophageal Reflux Disease (GERD) | - | - |
Sibutramine Hydrochloride Monohydrate | Phase 3 | Obesity | - | - |
Dotinurad | Phase 3 | Gout | - | - |
lemborexant | Phase 3 | Insomnia Disorder | - | - |
E3810 | Phase 3 | Non-erosive Gastroesophageal Reflux Disease | - | - |
Lamotrigine | Phase 3 | Epilepsy | - | - |
Perampanel | Phase 3 | Epilepsy | - | - |
T-614 | Phase 3 | Rheumatoid Arthritis | - | - |
Lorcaserin 10 mg once daily (QD) | Phase 3 | Obesity | - | - |
Lorcaserin 10 mg twice a day (BID) | Phase 3 | Obesity | - | - |
E2007 (perampanel) | Phase 3 | Refractory Partial Seizures | - | - |
fospropofol disodium | Phase 3 | Colonoscopy | - | - |
methylcobalamin | Phase 3 | Amyotrophic Lateral Sclerosis | - | - |
Rufinamide | Phase 3 | Lennox-Gastaut Syndrome | - | - |
Carbamazepine | Phase 3 | Epilepsy | - | - |
bexarotene | Phase 3 | Non-small Cell Lung Cancer | - | - |
Lecanemab | Phase 3 | Preclinical Alzheimer's Disease | - | - |
E2007 (2 mg) | Phase 3 | Diabetic Neuropathy | - | - |
Eszopiclone 1 mg | Phase 3 | Primary Insomnia | - | - |
E7389 | Phase 3 | Breast Cancer | - | - |
Midazolam HCl | Phase 3 | Colonoscopy | - | - |
LEM 5 mg | Phase 3 | Insomnia | - | - |
avatrombopag (higher baseline platelet count) | Phase 3 | Thrombocytopenia Associated With Liver Disease | - | - |
Cytarabine or Supportive Care | Phase 3 | Acute Myeloid Leukemia | - | - |
E2020 | Phase 3 | Alzheimer's Type Dementia | - | - |
Irofulven | Phase 3 | Prostate Cancer | - | - |
Eribulin | Phase 3 | Non-Small Cell Lung Cancer (NSCLC) | - | - |
Zonisamide | Phase 3 | Epilepsy; Paediatric Partial Onset Seizures | - | - |
Aricept | Phase 3 | Cognitive Impairment | - | - |
Eribulin Mesylate | Phase 3 | Breast Cancer | - | - |
Rufinamide (E2080) | Phase 3 | Lennox-Gastaut Syndrome | - | - |
avatrombopag (lower baseline platelet count) | Phase 3 | Thrombocytopenia Associated With Liver Disease | - | - |
Lorcaserin 10 mg BID | Phase 3 | Obesity | - | - |
Ranirestat | Phase 3 | Mild to Moderate Diabetic Sensorimotor Polyneuropathy | - | - |
eritoran tetrasodium | Phase 3 | Severe Sepsis | - | - |
Eribulin mesylate 1.4 mg/m^2 intravenous | Phase 3 | Soft Tissue Sarcoma | - | - |
Belzutifan | Phase 3 | Carcinoma, Renal Cell | - | - |
E2814 | Phase 3 | Alzheimer Disease | - | - |
Avatrombopag | Phase 3 | Chronic Thrombocytopenia | - | - |
AQUAVAN® (fospropofol disodium) Injection | Phase 3 | Bronchoscopy | - | - |
Gantenerumab | Phase 3 | Alzheimers Disease | - | - |
E7777 9 mcg/kg | Phase 3 | Persistent or Recurrent Cutaneous T-Cell Lymphoma | - | - |
phylloquinone (K1) | Phase 3 | Osteoporosis | - | - |
Aricept (donepezil SR 23 mg) | Phase 3 | Alzheimer's Disease | - | - |
Teprenone | Phase 3 | Gastric or Duodenal Ulcers Caused by Low-dose Aspirin | - | - |
Doxorubicin | Phase 3 | Breast Cancer | - | - |
Donepezil 5 mg | Phase 3 | Dementia With Lewy Bodies (DLB) | - | - |
Oxaliplatin | Phase 3 | Liver Cancer | - | - |
everolimus | Phase 3 | Renal Cell Carcinoma | - | - |
Carboplatin | Phase 3 | Endometrial Neoplasms | - | - |
Sorafenib | Phase 3 | Hepatocellular Carcinoma (HCC) | - | - |
Docetaxel | Phase 3 | Squamous Cell Carcinoma of Head and Neck | - | - |
Decitabine | Phase 3 | Acute Myeloid Leukemia | - | - |
Donepezil hydrochloride | Phase 3 | Attention Impairment | - | - |
Cinitapride | Phase 3 | Dyspepsia | - | - |
Lenvatinib | Phase 3 | Hepatocellular Carcinoma | - | - |
E2007 | Phase 3 | Refractory Partial Seizures | - | - |
Eperisone | Phase 3 | Muscle Spasm; Back Pain | - | - |
Eperisone hydrochloride and Diclofenac sodium | Phase 3 | Acute Musculoskeletal Spasm Due to Low Back Pain | - | - |
Zonegran | Phase 3 | Binge Eating Disorder Associated With Obesity | - | - |
Rabeprazole | Phase 3 | Gastric Ulcers Duodenal Ulcers Caused by Low-dose Aspirin | - | - |
Clevudine | Phase 3 | Chronic Hepatitis B | - | - |
Donepezil | Phase 3 | Alzheimer's Disease | - | - |
Ranitidine | Phase 3 | Gastroesophageal Reflux Disease (GERD) | - | - |
bexarotene with carboplatin and paclitaxel | Phase 3 | Non-small Cell Lung Cancer | - | - |
Amolimogene | Phase 3 | Uterine Cervical Dysplasia | - | - |
Donepezil HCl | Phase 3 | Down Syndrome | - | - |
E7337 | Phase 3 | Lesions of the Liver | - | - |
Prior Donepezil 5mg | Phase 3 | Parkinson's Disease | - | - |
E0302 (mecobalamin) | Phase 3 | Amyotrophic Lateral Sclerosis (ALS) | - | - |
Leucovorin (or Levoleucovorin) | Phase 3 | Advanced/Metastatic Gastroesophageal Adenocarcinoma | - | - |
H. pylori treatment | Phase 3 | Iron Deficiency Anemia | - | - |
Physician's Choice | Phase 3 | Breast Cancer | - | - |
E7389 (Eribulin Mesylate) | Phase 3 | HER2-Negative Breast Cancer | - | - |
2 mg perampanel | Phase 3 | Parkinson's Disease | - | - |
Midazolam HCI | Phase 3 | Conscious Sedation | - | - |
Pegylated interferon (PEG-IFN) | Phase 2 | Thrombocytopenia | - | - |
E7080 capsule | Phase 2 | Thyroid Cancer | - | - |
BOTULINUM TOXIN TYPE B | Phase 2 | Cervical Dystonia | - | - |
E7777 | Phase 2 | Peripheral T-cell Lymphoma | - | - |
Rabeprazole sodium, 5 mg Tablets | Phase 2 | Healthy | - | - |
E7090 | Phase 2 | Cholangiocarcinoma | - | - |
E5555 50 mg | Phase 2 | Coronary Artery Disease | - | - |
Tazemetostat | Phase 2 | Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma | - | - |
E6742 | Phase 2 | Lupus Erythematosus, Systemic | - | - |
E7050 | Phase 2 | Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck | - | - |
E2014 (Botulinum toxin type B) | Phase 2 | Spasmodic Torticollis | - | - |
Farletuzumab | Phase 2 | Platinum-Sensitive Ovarian Cancer in First Relapse | - | - |
Irofulven + capecitabine | Phase 2 | Thyroid Cancer | - | - |
BB-1701 | Phase 2 | Breast Cancer | - | - |
E7449 alone | Phase 2 | Malignant Solid Tumour | - | - |
APD356 | Phase 2 | Obesity | - | - |
ONTAK (denileukin diftitox) | Phase 2 | Lymphoma, B-Cell | - | - |
Iomeprole | Phase 2 | Lesion | - | - |
Eribulin mesilate | Phase 2 | Refractory or Recurrent Solid Tumors | - | - |
E7070 | Phase 2 | Kidney Neoplasms | - | - |
Lenvatinib (DTC Cohort) | Phase 2 | Thyroid Cancer | - | - |
Palonosetron | Phase 2 | Multiple Myeloma | - | - |
E7080 | Phase 2 | Solid Tumors | - | - |
ONTAK | Phase 2 | Non-Hodgkin's Lymphoma | - | - |
E6011 | Phase 2 | Rheumatoid Arthritis | - | - |
GPI 1485 | Phase 2 | Parkinson's Disease | - | - |
Denileukin diftitox | Phase 2 | Stage IIIC Melanoma | - | - |
Farletuzumab ecteribulin | Phase 2 | Solid Tumor | - | - |
E2006 | Phase 2 | Chronic Insomnia | - | - |
E7820 plus cetuximab | Phase 2 | Advanced Colorectal Cancer | - | - |
Lecanemab 2.5 mg/kg | Phase 2 | Alzheimer's Disease | - | - |
GLIADEL | Phase 2 | Metastatic Brain Cancer | - | - |
palonesetron | Phase 2 | Patients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LEC | - | - |
H3B-6545 | Phase 2 | Breast Neoplasms | - | - |
E7386 | Phase 2 | Melanoma | - | - |
Avatrombopag tablets | Phase 2 | Chronic Idiopathic Thrombocytopenic Purpura | - | - |
AQUAVAN (fospropofol disodium; GPI 15715 ) | Phase 2 | Postoperative Sedation | - | - |
Lemborexant 2.5 mg | Phase 2 | Irregular Sleep-Wake Rhythm Disorder | - | - |
E5564 | Phase 2 | Sepsis | - | - |
Irsenontrine | Phase 2 | Dementia With Lewy Bodies | - | - |
E5555 | Phase 2 | Coronary Artery Disease | - | - |
fospropofol | Phase 2 | Ischemic Coronary Artery Disease | - | - |
E6201 0.005% | Phase 2 | Chronic Plaque Psoriasis | - | - |
Rabeprazole 20 mg | Phase 2 | Gastroesophageal Reflux Disease | - | - |
E7389 28 Day Cycle | Phase 2 | Non-Small-Cell Lung Carcinoma | - | - |
Perampanel Oral Suspension | Phase 2 | Pediatric Epileptic Syndrome | - | - |
E7389-LF | Phase 2 | Solid Neoplasms | - | - |
Ixabepilone | Phase 2 | Breast Cancer | - | - |
MORAb-004 (monoclonal antibody) | Phase 2 | Metastatic Melanoma | - | - |
BSC | Phase 2 | Non-Small Cell Lung Cancer | - | - |
Open Label (Avatrombopag tablets) | Phase 2 | Idiopathic Thrombocytopenic Purpura | - | - |
E2027 | Phase 2 | Lewy Body Disease | - | - |
0.03% E6201 | Phase 2 | Psoriasis Vulgaris | - | - |
E2086 | Phase 2 | Narcolepsy | - | - |
Rabeprazole 20 mg twice a day for 90-day period treatment | Phase 2 | Postnasal Drainage | - | - |
Clofarabine | Phase 2 | Acute Myeloid Leukemia | - | - |
Lenvatinib + Letrozole | Phase 2 | Breast Cancer | - | - |
E7820 | Phase 2 | Acute Myeloid Leukemia | - | - |
decitabine (5-aza-2'deoxycytidine) | Phase 2 | Chronic Myelogenous Leukemia | - | - |
Valproic acid | Phase 2 | Leukemia | - | - |
Estrogen | Phase 2 | Alzheimer Disease | - | - |
Palonosetron (PALO) | Phase 2 | Malignant Glioma | - | - |
Idarubicin | Phase 2 | Leukemia | - | - |
Lenvatinib Pill | Phase 2 | Hepatocellular Carcinoma | - | - |
E2020-Donepezil hydrochloride | Phase 2 | Down Syndrome | - | - |
Gemtuzumab ozogamicin | Phase 2 | Acute Myelogenous Leukemia | - | - |
Adriamycin | Phase 2 | Inflammatory Breast Cancer | - | - |
Ondansetron | Phase 2 | Acute Myelogenous Leukemia | - | - |
3 mg Donepezil hydrochloride | Phase 2 | Dementia With Lewy Bodies (DLB) | - | - |
Eribulin mesylate (eribulin; E7389) | Phase 2 | Non Small Cell Lung Cancer | - | - |
Aricept (donepezil hydrochloride) | Phase 2 | Migraine Headache | - | - |
(+)-SJ000557733 (SJ733) | Phase 2 | Malaria, Falciparum | - | - |
eribulin mesylate + erlotinib | Phase 2 | Non-small Cell Lung Cancer | - | - |
Lemborexant 10 mg | Phase 2 | Alzheimer Disease | - | - |
CHOP (cyclophosphamide (C), adriamycin (H), vincristine (O), and prednisone (P)) chemotherapy | Phase 2 | Peripheral T-Cell Lymphoma | - | - |
Decitabine, Arsenic Trioxide and Ascorbic Acid | Phase 2 | Myelodysplastic Syndrome | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Eisai's drug pipeline?→
CatalystAlert tracks 156 drug candidates in Eisai's (ESALY) pipeline across Phase 3, Phase 2. Its lead program is Zolpidem tartrate (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Eisai's next FDA catalyst?→
Eisai's (ESALY) next tracked catalyst is a Phase 2 expected November 1, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ESALY biotech catalysts?→
Add ESALY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Eisai's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.